QureTech Bio receives excellent support for development of new antibiotics
QureTech Bio receives support for development of new antibiotics March, [...]
QureTech Bio receives support for development of new antibiotics March, [...]
Reflection from QureTech Bio’s CEO January, 2022 A reflection [...]
QureTech Bio founders in major US investment to combat antibiotic [...]
QureTech Bio expands workforce following major investmentApril, 2021Umeå-based pharmaceutical development [...]
QureTech Bio Looks to the Future With Appointment of New [...]
Scott Hultgren, CSO of QureTech Bio and Helen L. Stoever [...]
Fredrik Almqvist, CEO of QureTech Bio based in Umeå in [...]
Venture capital company Nascent Invest has bought shares in Umeå-based [...]
Umeå-based QureTech Bio has received preliminary approval for a patent [...]
Umeå life science company QureTech Bio has received a SEK [...]